RadNet, Inc. (RDNT) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1510 COTNER AVE LOS ANGELES, CA 90025 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 740 | 343 | 128 | 135 | 102 | 40 | |||
| Cash and cash equivalent | 740 | 343 | 128 | 135 | 102 | 40 | |||
| Receivables | 186 | 164 | 185 | 140 | 135 | 156 | |||
| Other undisclosed current assets | 93 | 73 | 54 | 49 | 33 | 47 | |||
| Total current assets: | 1,019 | 579 | 367 | 324 | 270 | 243 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 0 | 1 | 2 | 5 | 8 | 11 | |||
| Operating lease, right-of-use asset | 640 | 596 | 604 | 584 | 484 | 445 | |||
| Property, plant and equipment | 695 | 604 | 566 | 367 | |||||
| Long-term investments and receivables | 104 | 93 | 58 | 42 | 35 | 34 | |||
| Long-term investments | 104 | 93 | 58 | 42 | 35 | 34 | |||
| Intangible assets, net (including goodwill) | 792 | 770 | 784 | 570 | 525 | 484 | |||
| Goodwill | 711 | 679 | 678 | 514 | 473 | 441 | |||
| Intangible assets, net (excluding goodwill) | 81 | 91 | 106 | 57 | 52 | 43 | |||
| Deferred income tax assets | 15 | 35 | |||||||
| Other undisclosed noncurrent assets | 36 | 47 | 54 | 518 | 430 | 62 | |||
| Total noncurrent assets: | 2,267 | 2,111 | 2,067 | 1,734 | 1,516 | 1,404 | |||
| TOTAL ASSETS: | 3,287 | 2,690 | 2,434 | 2,058 | 1,787 | 1,647 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 351 | 343 | 370 | 264 | 237 | 208 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 62 | 58 | 42 | ||
| Accounts payable | 96 | 123 | 103 | 86 | 70 | 64 | |||
| Accrued liabilities | 153 | 124 | 182 | 93 | 84 | 84 | |||
| Other undisclosed accounts payable and accrued liabilities | 102 | 96 | 85 | 22 | 24 | 17 | |||
| Deferred revenue | 3 | 5 | 4 | 11 | 1 | 1 | |||
| Debt | 25 | 18 | 12 | 11 | 42 | 104 | |||
| Due to related parties | ✕ | ✕ | ✕ | 23 | 24 | 14 | 14 | ||
| Other undisclosed current liabilities | 100 | 72 | 58 | 65 | 104 | 0 | |||
| Total current liabilities: | 480 | 437 | 467 | 375 | 398 | 327 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 992 | 812 | 839 | 1,321 | 662 | 706 | |||
| Long-term debt, excluding current maturities | 992 | 812 | 839 | 743 | 613 | 653 | |||
| Finance lease, liability | 1 | 3 | |||||||
| Other undisclosed long-term debt and lease obligation | (414) | (371) | |||||||
| Liabilities, other than long-term debt | 682 | 628 | 636 | 16 | 53 | 12 | |||
| Deferred income tax liabilities | 22 | 16 | 9 | ||||||
| Off-market lease, unfavorable | 2 | ||||||||
| Other liabilities | 4 | 7 | 23 | 16 | 53 | 10 | |||
| Operating lease, liability | 656 | 605 | 604 | 578 | 463 | 421 | |||
| Other undisclosed noncurrent liabilities | 414 | 369 | |||||||
| Total noncurrent liabilities: | 1,674 | 1,440 | 1,476 | 1,338 | 1,130 | 1,086 | |||
| Total liabilities: | 2,153 | 1,877 | 1,942 | 1,712 | 1,528 | 1,414 | |||
| Equity | |||||||||
| Equity, attributable to parent | 902 | 631 | 333 | 229 | 166 | 152 | |||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 988 | 723 | 436 | 343 | 308 | 263 | |||
| Accumulated other comprehensive income (loss) | (9) | (12) | (21) | (20) | (24) | (8) | |||
| Accumulated deficit | (77) | (80) | (83) | (93) | (118) | (103) | |||
| Equity, attributable to noncontrolling interest | 231 | 183 | 158 | 117 | 93 | 81 | |||
| Total equity: | 1,133 | 813 | 491 | 346 | 258 | 233 | |||
| TOTAL LIABILITIES AND EQUITY: | 3,287 | 2,690 | 2,434 | 2,058 | 1,787 | 1,647 | |||
Income Statement (P&L) ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,830 | 1,617 | 1,430 | 1,315 | 1,072 | 1,154 | ||
| Cost of revenue | (1,000) | |||||||
| Gross profit: | 1,830 | 1,617 | 1,430 | 1,315 | 1,072 | 154 | ||
| Operating expenses | (1,725) | (1,518) | (1,384) | (1,242) | (1,062) | (1,084) | ||
| Other undisclosed operating income | 9 | 26 | 1,000 | |||||
| Operating income: | 105 | 99 | 46 | 83 | 36 | 70 | ||
| Nonoperating expense | (60) | (60) | (3) | (24) | (37) | (40) | ||
| Other nonoperating income (expense) | 25 | 6 | (2) | (1) | (0) | (1) | ||
| Interest and debt expense | (4) | (64) | (51) | (2) | (5) | (5) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 2 | 5 | 5 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 41 | (26) | (8) | 59 | (1) | 30 | ||
| Income from equity method investments | 11 | 8 | ||||||
| Other undisclosed income from continuing operations before income taxes | 4 | 64 | 51 | |||||
| Income from continuing operations before income taxes: | 45 | 39 | 43 | 70 | 7 | 30 | ||
| Income tax expense | (6) | (8) | (9) | (15) | (1) | (6) | ||
| Income from continuing operations: | 39 | 30 | 34 | 55 | 6 | 23 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 55 | 6 | 23 | |
| Other undisclosed net loss | (11) | (8) | ||||||
| Net income (loss): | 39 | 30 | 34 | 44 | (2) | 23 | ||
| Net loss attributable to noncontrolling interest | (36) | (27) | (23) | (20) | (13) | (9) | ||
| Net income (loss) available to common stockholders, basic: | 3 | 3 | 11 | 25 | (15) | 15 | ||
| Other undisclosed net loss available to common stockholders, diluted | (1) | |||||||
| Net income (loss) available to common stockholders, diluted: | 3 | 3 | 10 | 25 | (15) | 15 | ||
Comprehensive Income ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 39 | 30 | 34 | 44 | (2) | 23 | ||
| Other comprehensive income (loss) | (6) | 5 | (4) | |||||
| Other undisclosed comprehensive income (loss) | 9 | 4 | 4 | 4 | (16) | (10) | ||
| Comprehensive income (loss): | 42 | 39 | 33 | 48 | (18) | 13 | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (36) | (27) | (23) | (20) | (13) | (9) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 6 | 11 | 10 | 28 | (31) | 4 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.